Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Melanoma thickness at diagnosis is linked to access to dermatologists and preventive services, not to socioeconomic status.

Living near more dermatologists and using certain cancer screening tests lowers the chance of being diagnosed with advanced skin cancer.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

The document listed medical job ads and guidelines for breast cancer screening.

Early diagnosis and treatment of TPP can prevent complications.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Breast cancer may be detectable through changes in scalp hair lipids.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Finasteride for hair loss may cause gynecomastia; doctors should inform patients.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.